Tamara Maes
Founder en ORYZON GENOMICS S.A. .
Fortuna: 5 M $ al 31/03/2024
Cargos activos de Tamara Maes
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ORYZON GENOMICS S.A. | Director/Board Member | 02/06/2000 | - |
| Founder | 02/06/2000 | - | |
| Chief Tech/Sci/R&D Officer | 02/06/2000 | 02/11/2020 | |
| Oncnosis Pharma AIE | Corporate Officer/Principal | - | - |
Mendelion Lifesciences SL
 Mendelion Lifesciences SL Engineering & ConstructionIndustrial Services Mendelion Lifesciences SL constructs commercial buildings. | Director/Board Member | - | - |
Alzheimers Drug Discovery Foundation
 Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr. | Corporate Officer/Principal | 01/01/2016 | - |
Historial de carrera de Tamara Maes
Formación de Tamara Maes.
| Ghent University | Doctorate Degree |
Estadísticas
Internacional
| España | 4 |
| Bélgica | 2 |
| Estados Unidos | 2 |
Operativa
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
| Industrial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ORYZON GENOMICS S.A. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Alzheimers Drug Discovery Foundation
Alzheimers Drug Discovery Foundation BiotechnologyHealth Technology The Alzheimer's Drug Discovery Foundation (ADDF) is a public charity founded in 1998 by Ronald Steven Lauder, Leonard Alan Lauder, and Howard Fillit. The non-profit company is based in New York, NY. The ADDF is dedicated to accelerating the discovery of drugs to prevent, treat, and cure Alzheimer's disease. The company is the only public charity solely focused on funding the development of drugs for Alzheimer's, using a venture philanthropy model to support research in academia and the biotech industry. The ADDF has awarded over $209 million to fund over 690 Alzheimer's drug discovery programs, biomarker programs, and clinical trials in 19 countries. The CEO is Mark Roithmayr. | Health Technology |
| Oncnosis Pharma AIE | |
Mendelion Lifesciences SL
Mendelion Lifesciences SL Engineering & ConstructionIndustrial Services Mendelion Lifesciences SL constructs commercial buildings. | Industrial Services |
- Bolsa de valores
- Insiders
- Tamara Maes
- Experiencia
